Management of marker negative stage II testicular cancer

Dr Kollmannsberger speaks with ecancer at the 2018 ASCO Genitourinary Cancers Symposium about the management of marker negative stage II testicular cancer. He then goes on to discuss treatment challenges in testicular cancer in general and highlights the need to improve the quality of care on a broad basics across the world.